As BioPharma Services expands its Phase I and late Phase offering, we are pleased to announce the addition of Muhammad Bilal to the BioPharma team. In his role as Director of Clinical Data Operations, Bilal will expand our scope, capabilities and capacity for providing Early Phase support for advanced and specialized Phase I studies. BioPharma will also be expanding its ability to support stand-alone Data Management activities for Phase I, II and III studies.
Having held leadership roles at INC Research (now Syneos) and Topstone, Bilal brings his extensive Data Management, programming and leadership experience to the BioPharma team. His thorough understanding of Data Management processes along with his proven ability to build Data Management teams and offer new services will help the BioPharma team grow and provide the full service support that our clients rely on.
About BioPharma Services Inc.
BioPharma Services Inc. is a fullservice Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma has clinical facilities both in the USA and Canada with a total capacity of 300 beds with access to healthy volunteers and special populations. Headquartered in Toronto, Canada, BioPharma’s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Medical Writing and Data Management.
Main Telephone: +1 844 747 8484
Ms. Anna Taylor, Executive Vice President, Business Development, BioPharma Services, Inc.